HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival following lung transplantation for artificial stone silicosis relative to idiopathic pulmonary fibrosis.

AbstractBACKGROUND:
Silicosis is a progressive lung disease resulting from the inhalation of respirable crystalline silica. Lung transplantation is the only treatment for end-stage silicosis. The aim of this study was to analyze the survival experience following lung transplantation among patients with silicosis.
METHODS:
We reviewed data for all patients who underwent lung transplantation for silicosis and a matched group undergoing lung transplantation for idiopathic pulmonary fibrosis (IPF) at a single medical center between March 2006 and the end of December 2013. Survival was followed through 2015.
RESULTS:
A total of 17 lung transplantations were performed for silicosis among 342 lung transplantations (4.9%) during the study period. We observed non-statistically significant survival advantage (hazard ratio 0.6; 95%CI 0.24-1.55) for those undergoing lung transplantation for silicosis relative to IPF patients undergoing lung transplantation during the same period.
CONCLUSIONS:
Within the limits of a small sample, survival in silicosis patients following lung transplantation was not reduced compared to IPF. Am. J. Ind. Med. 60:248-254, 2017. © 2017 Wiley Periodicals, Inc.
AuthorsDror Rosengarten, Benjamin D Fox, Elizabeth Fireman, Paul D Blanc, Victoria Rusanov, Oren Fruchter, Yael Raviv, Osnat Shtraichman, Milton Saute, Mordechai R Kramer
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 60 Issue 3 Pg. 248-254 (Mar 2017) ISSN: 1097-0274 [Electronic] United States
PMID28145560 (Publication Type: Evaluation Study, Journal Article)
Copyright© 2017 Wiley Periodicals, Inc.
Topics
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis (surgery)
  • Lung Transplantation (mortality)
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Retrospective Studies
  • Silicosis (etiology, surgery)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: